organoids Archives - HCS Pharma

Biomimesys

Poster – (ECM 2022) Development of innovative hiPSC-based model including an innovative 3D modified hyaluronic acid hydroscaffold for phenotypic screening

We previously showed that human pluripotent stem cells (hiPSCs) provide a suitable model to studymetabolic diseases upon hepatocyte-like cell (HLC) differentiation. With a non-invasive approach, hiPSCs can be generated from urine samples of patients and HLCs have been used to model cholesterol metabolism regulation, by the study of LDLR- and Read more…

By Grégory MAUBON, 3 monthsJuly 18, 2022 ago

Biomimesys

Webinar “BIOMIMESYS® Liver for 3D in vitro models : applications and examples”

When Tuesday, May 31, 2022 – 9AM (CEST) / 3PM (CST) / 4PM (JST) / 3AM (EST) Thursday, June 2, 2022 – 1PM (CEST) / 7PM (CST) / 8PM (JST) / 7AM (EST) Where Online, using zoom.us and live on Youtube What 3D cell culture systems have recently emerged as Read more…

By Méryl Roudaut, 5 monthsMay 10, 2022 ago

Biomimesys

HCS Pharma était présent au Workshop OoC 2022 (article in french)

HCS Pharma était présent au Workshop OoC pour une création et une structuration de la filière, organisé par Biovalley à l’Institut Pierre-Gilles de Gennes (Paris). Nous sommes très heureux d’avoir pu sponsoriser l’événement, mais aussi tout simplement d’y avoir participé – en présentiel – et de pouvoir discuter avec des chercheurs Read more…

By Elodie Vandenhaute, 7 monthsMarch 8, 2022 ago

Biomimesys

Collaboration between “Institut du thorax” and HCS Pharma: improving the management of hypercholesterolemia using a relevant and innovative organoid-based in vitro liver model

Launched in 2016, the adventure is coming to an end after 5 years of work carried out within the RHU CHOPIN (CHOlesterol Personalized INnovation), and with a strong collaboration between HCS Pharma and l’Institut du thorax. This collaborative project of national scope was led by Professor Bertrand Cariou, director of Read more…

By Grégory MAUBON, 10 monthsDecember 9, 2021 ago

Biomimesys

Meryl’s presentation at 17th ISVHLD GHS 2021 about liver organoids in BIOMIMESYS®

Our project leader Dr Meryl Roudaut was invited to present at the last ISVHLD congress, the Global Hepatitis Summit, in Taiwan. The theme of the summit, “Evolution and Revolution of Viral Hepatitis and Liver Disease”, was perfect to talk about the use of BIOMIMESYS® product to overcome the limitations of Read more…

By Grégory MAUBON, 1 yearJuly 15, 2021 ago

News

Lucille joins us to develop hepatocellular models and hiPSCs-derived liver organoids

We are very happy to welcome Lucille in our laboratory. Lucille is currently finishing a master degree in Biotechnologies at AgroParisTech, a French engineering school. During her studies, she had the opportunity to work with 3D vascularised cellular models in the Herland Lab of KTH, Royal Institute of Technology, in Read more…

By Grégory MAUBON, 1 yearApril 6, 2021 ago

Biomimesys

Applications for 3D in vitro models with BIOMIMESYS® Liver

3D cell culture systems have recently emerged as promising tools for reproducing the cellular environment and the organization of tissues/organs, where cells are connected to each other and to the surrounding extracellular matrix (ECM). In this presentation we will focus on BIOMIMESYS® Liver and will discuss about its different applications. Read more…

By Grégory MAUBON, 2 yearsMarch 30, 2021 ago

News

Meet Meryl in Rennes at the next “Liver Week”

The 8th edition of the Symposium of “Functional Genomics of the Liver” (GFF) will be held from 26 to 28 February 2020 in Rennes, at the Couvent des Jacobins. Meryl, from our team, will be present with a poster about hiPSCs-derived liver organoids made with BIOMIMESYS® Liver hydroscaffold. If you Read more…

By Grégory MAUBON, 3 yearsFebruary 24, 2020 ago

Biomimesys

Poster – Development and automation of 3D innovative hiPSC-based liver organoids including the microenvironment for phenotypic screening – Application on metabolic diseases – version DHU2020

Ask for high quality link by putting your email below We previously showed that human pluripotent stem cells (hiPSCs) provide a suitable model to study metabolic diseases upon hepatocyte-like cell (HLC) differentiation. In particular, HLCs have been used to model cholesterol metabolism regulation, by mimicking the main disease features in Read more…

By Grégory MAUBON, 3 yearsDecember 19, 2019 ago

Biomimesys

Poster – Development and automation of 3D innovative hiPSC-based liver organoids including the microenvironment for phenotypic screening – Application on metabolic diseases

We previously showed that human pluripotent stem cells (hiPSCs) provide a suitable model to study metabolic diseases upon hepatocyte-like cell (HLC) differentiation. In particular, HLCs have been used to model cholesterol metabolism regulation, by mimicking the main disease features in vitro. Human iPSCs can be generated from urine samples of Read more…

By Grégory MAUBON, 3 yearsSeptember 16, 2019 ago

HCS, HCA & Biology

SelectBio events on 3D culture and biochip systems last week : surprises and possibilities!

It was a great pleasure to be invited (thanks to our partner Molecular Devices) to present our work during these 2 events organized by selectBio in Rotterdam: Organoids and Tox Screening Europe 2019 on June 13-14 Organ-on-a-Chip and Tissue-on-a-Chip Europe 2019 on June 18-19 Both were of great interest for Read more…

By Grégory MAUBON, 3 yearsJune 26, 2019 ago

News

This month we welcome you in Rotterdam to talk about 3D cell culture technology for HCS

We will be present this week and next week in Rotterdam, to talk about 3D cell culture and the importance of the microenvironnement in the relevance of in vitro models. As you known, to mimic human tissues, several parameters need to be taken into account: the target cells, nutrient intake Read more…

By Grégory MAUBON, 3 yearsJune 10, 2019 ago

HCS, HCA & Biology

Human in vitro micro-organs

Using iPS, researchers are moving very quickly in understanding cell differentiation and already manage to recreate a mini-organ in vitro after 20-30 days of differentiation

By Nathalie MAUBON, 7 yearsApril 4, 2016 ago